Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17015-08-6

Post Buying Request

17015-08-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17015-08-6 Usage

General Description

(2R,3R)-(-)-Epoxysuccinic acid, also known as L-tartaric acid, is an organic compound with the formula C4H6O6. It is a non-toxic, colorless, crystalline solid that is soluble in water and mildly soluble in alcohol. It has two chiral centers, giving it two stereoisomers, and it belongs to the class of organic compounds known as tartaric acids and derivatives. This chemical is a strong acid and can serve as an antioxidant. Additionally, it is commonly used in the food and beverage industry as an acidity regulator, and also has applications in pharmaceuticals, as well as in the manufacture of cement and plaster of Paris. L-tartaric acid is naturally found in various fruits and is one of the main acids found in wine.

Check Digit Verification of cas no

The CAS Registry Mumber 17015-08-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,0,1 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 17015-08:
(7*1)+(6*7)+(5*0)+(4*1)+(3*5)+(2*0)+(1*8)=76
76 % 10 = 6
So 17015-08-6 is a valid CAS Registry Number.

17015-08-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R,3R)-oxirane-2,3-dicarboxylic acid

1.2 Other means of identification

Product number -
Other names epoxyfumaric acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17015-08-6 SDS

17015-08-6Synthetic route

trans-2,3-bis(ethoxycarbonyl)oxirane
74243-85-9

trans-2,3-bis(ethoxycarbonyl)oxirane

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 3h; Ambient temperature;93%
(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

Conditions
ConditionsYield
With dihydrogen peroxide; sodium tungstate60%

A

(-)-trans-2,3-oxiranedicarboxylic acid
17087-75-1

(-)-trans-2,3-oxiranedicarboxylic acid

B

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

Conditions
ConditionsYield
Resolution of racemate;A 46%
B 41%
D-glucose
50-99-7

D-glucose

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

Conditions
ConditionsYield
mit Hilfe von Aspergillus fumigatus;
(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

Conditions
ConditionsYield
ueber das Morphin-Salz;
Yield given;
acetate of dimethyl ester of/the/ levorotatory β-chloro-malic acid I

acetate of dimethyl ester of/the/ levorotatory β-chloro-malic acid I

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

Conditions
ConditionsYield
With hydrogenchloride; methanol; water Behandeln des Reaktionsprodukts mit Natronlauge;
diethyl ester of/the/ levorotatory β-chloro-malic acid I

diethyl ester of/the/ levorotatory β-chloro-malic acid I

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

Conditions
ConditionsYield
With hydrogenchloride Behandeln mit verduennter Natronlauge;
methylamine
74-89-5

methylamine

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

L-erythro-N(α)-methyl-3-hydroxy-L-aspartic acid

L-erythro-N(α)-methyl-3-hydroxy-L-aspartic acid

Conditions
ConditionsYield
In water Reflux;90%
(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

2-(S)-amino-3-(R)-hydroxysuccinic acid
7298-98-8

2-(S)-amino-3-(R)-hydroxysuccinic acid

Conditions
ConditionsYield
With ammonium hydroxide; water at 45 - 47℃; for 48h;82%
With ammonium hydroxide at 110℃; for 30h;42%
With ammonium hydroxide
N-α-tert-butyloxycarbonyl-L-diaminopropanoic acid tert-butyl ester
77215-54-4

N-α-tert-butyloxycarbonyl-L-diaminopropanoic acid tert-butyl ester

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

Nβ-(R,R)-epoxysuccinoyl-DAP(BOC)-Otbu
1255383-49-3

Nβ-(R,R)-epoxysuccinoyl-DAP(BOC)-Otbu

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 12h;79%
(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

sodium thiomethoxide
5188-07-8

sodium thiomethoxide

sodium (2S,3S)-(-)-3-methylmercaptomalate

sodium (2S,3S)-(-)-3-methylmercaptomalate

Conditions
ConditionsYield
Stage #1: (2R,3R)-oxirane-2,3-dicarboxylic acid With sodium hydroxide In water pH=7;
Stage #2: sodium thiomethoxide In water at 0℃;
Stage #3: With acetic acid In water pH=10;
57%
(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

DL-erythro-β-hydroxyaspartic acid

DL-erythro-β-hydroxyaspartic acid

Conditions
ConditionsYield
Stage #1: (2R,3R)-oxirane-2,3-dicarboxylic acid With ammonium hydroxide In water at 50℃; for 24h;
Stage #2: With hydrogenchloride In water at 4℃; for 72h; pH=3;
55.1%
mercaptoacetic acid
68-11-1

mercaptoacetic acid

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

(2S,3S)-(-)-thiahomoisocitrate
1377677-68-3

(2S,3S)-(-)-thiahomoisocitrate

Conditions
ConditionsYield
With sodium hydroxide In water at 80℃; for 10h; pH=12;42%
(-)-trans-2,3-oxiranedicarboxylic acid
17087-75-1

(-)-trans-2,3-oxiranedicarboxylic acid

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

A

meso-tartaric acid
147-73-9

meso-tartaric acid

B

L-Tartaric acid
87-69-4

L-Tartaric acid

Conditions
ConditionsYield
With water
With potassium hydroxide
benzylamine
100-46-9

benzylamine

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

D-(-)-Benzyl-erythro-β-hydroxy-asparaginsaeure
17126-60-2

D-(-)-Benzyl-erythro-β-hydroxy-asparaginsaeure

Conditions
ConditionsYield
In water Heating;
hydrogenchloride
7647-01-0

hydrogenchloride

diethyl ether
60-29-7

diethyl ether

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

(-)(2S:3S)-3-chloro-2-hydroxy-succinic acid
74841-95-5

(-)(2S:3S)-3-chloro-2-hydroxy-succinic acid

Conditions
ConditionsYield
at 20℃;
water
7732-18-5

water

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

A

L-Tartaric acid
87-69-4

L-Tartaric acid

B

acetaldehyde
75-07-0

acetaldehyde

C

tartaric acid
87-69-4

tartaric acid

Conditions
ConditionsYield
Product distribution;
(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

benzyl alcohol
100-51-6

benzyl alcohol

(2R,3R)-oxirane-2,3-dicarboxylic acid monobenzyl ester
646532-93-6

(2R,3R)-oxirane-2,3-dicarboxylic acid monobenzyl ester

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 15h;
Conditions
ConditionsYield
With hydrogenchloride; ammonium hydroxide In water73.1 g (81.7%)
Fmoc-Ser(tBu)-Wang resin

Fmoc-Ser(tBu)-Wang resin

(S)-O-tert-butylserine
18822-58-7

(S)-O-tert-butylserine

5-trityl-L-glutamine
102747-84-2

5-trityl-L-glutamine

L-proline
147-85-3

L-proline

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

C25H37N7O12
1631180-58-9

C25H37N7O12

Conditions
ConditionsYield
Stage #1: Fmoc-Ser(tBu)-Wang resin With piperidine; 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide Rink-amide MBHA resin;
Stage #2: L-proline With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 1h; Rink-amide MBHA resin;
Stage #3: (S)-O-tert-butylserine; 5-trityl-L-glutamine; L-proline; (2R,3R)-oxirane-2,3-dicarboxylic acid Further stages;
Fmoc-Ser(tBu)-Wang resin

Fmoc-Ser(tBu)-Wang resin

L-proline
147-85-3

L-proline

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

(S)-2-amino-5-(3-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl)guanidino)pentanoic acid

(S)-2-amino-5-(3-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl)guanidino)pentanoic acid

C28H43N9O10
1631179-75-3

C28H43N9O10

Conditions
ConditionsYield
Stage #1: Fmoc-Ser(tBu)-Wang resin With piperidine; 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide Rink-amide MBHA resin;
Stage #2: L-proline With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 1h; Rink-amide MBHA resin;
Stage #3: L-proline; (2R,3R)-oxirane-2,3-dicarboxylic acid; (S)-2-amino-5-(3-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl)guanidino)pentanoic acid Further stages;
Fmoc-Ser(tBu)-Wang resin

Fmoc-Ser(tBu)-Wang resin

(O-tert-butyl)-L-threonine
4378-13-6

(O-tert-butyl)-L-threonine

L-proline
147-85-3

L-proline

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

C26H38N6O11
1631180-28-3

C26H38N6O11

Conditions
ConditionsYield
Stage #1: Fmoc-Ser(tBu)-Wang resin With piperidine; 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide Rink-amide MBHA resin;
Stage #2: L-proline With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 1h; Rink-amide MBHA resin;
Stage #3: (O-tert-butyl)-L-threonine; L-proline; (2R,3R)-oxirane-2,3-dicarboxylic acid Further stages;
Fmoc-Ser(tBu)-Wang resin

Fmoc-Ser(tBu)-Wang resin

(S)-O-tert-butylserine
18822-58-7

(S)-O-tert-butylserine

L-proline
147-85-3

L-proline

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

C25H36N6O11
1631179-65-1

C25H36N6O11

Conditions
ConditionsYield
Stage #1: Fmoc-Ser(tBu)-Wang resin With piperidine; 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide Rink-amide MBHA resin;
Stage #2: L-proline With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 1h; Rink-amide MBHA resin;
Stage #3: (S)-O-tert-butylserine; L-proline; (2R,3R)-oxirane-2,3-dicarboxylic acid Further stages;
Fmoc-Ser(tBu)-Wang resin

Fmoc-Ser(tBu)-Wang resin

(S)-O-tert-butylserine
18822-58-7

(S)-O-tert-butylserine

L-proline
147-85-3

L-proline

(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

C23H34N6O12
1631180-31-8

C23H34N6O12

Conditions
ConditionsYield
Stage #1: Fmoc-Ser(tBu)-Wang resin With piperidine; 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide Rink-amide MBHA resin;
Stage #2: L-proline With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 1h; Rink-amide MBHA resin;
Stage #3: (S)-O-tert-butylserine; L-proline; (2R,3R)-oxirane-2,3-dicarboxylic acid Further stages;
(2R,3R)-oxirane-2,3-dicarboxylic acid
17015-08-6

(2R,3R)-oxirane-2,3-dicarboxylic acid

A

erythro-β-hydroxy-D-aspartic acid
5753-30-0

erythro-β-hydroxy-D-aspartic acid

B

2-(S)-amino-3-(R)-hydroxysuccinic acid
7298-98-8

2-(S)-amino-3-(R)-hydroxysuccinic acid

Conditions
ConditionsYield
With ammonium hydroxide at 0 - 48℃; for 48h;

17015-08-6Relevant articles and documents

-

Oh-hashi,J.-I.,Harada,K.

, p. 2977 - 2979 (1967)

-

Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors

Dókus, Levente E.,Menyhárd, Dóra K.,Tantos, ágnes,Hudecz, Ferenc,Bánóczi, Zoltán

, p. 274 - 280 (2014/06/24)

Calpains are intracellular cysteine proteases with important physiological functions. Up- or downregulation of their expression can be responsible for several diseases, therefore specific calpain inhibitors may be considered as promising candidates for drug discovery. In this paper we describe the synthesis and characterization of a new class of inhibitors derived from the analysis of amino acid preferences in primed and unprimed sites of calpains by incorporation of l- or d-epoxysuccinyl group (Eps). Amino acids for replacement were chosen by considering the substrate preference of calpain 1 and 2 enzymes. The compounds were characterized by RP-HPLC, amino acid analysis and ESI-MS. Selectivity of the compounds was studied by using calpain 1 and 2; and cathepsin B. We have identified five calpain specific inhibitors with different extent of selectivity. Two of these also exhibited isoform selectivity. Compound NH 2-Thr-Pro-Leu-(d-Eps)-Thr-Pro-Pro-Pro-Ser-NH2 proved to be a calpain 2 enzyme inhibitor with at least 11.8-fold selectivity, while compound NH2-Thr-Pro-Leu-(l-Eps)-Ser-Pro-Pro-Pro-Ser-NH2 possesses calpain 1 enzyme inhibition with at least 4-fold selectivity. The results of molecular modeling calculations suggest that the orientation of the bound inhibitor in the substrate binding cleft is markedly dependent on the stereochemistry of the epoxysuccinyl group.

Design, Synthesis, and Evaluation of Aza-Peptide Epoxides as Selective and Potent Inhibitors of Caspases-1, -3, -6, and -8

James, Karen Ellis,Asgian, Juliana L.,Li, Zhao Zhao,Ekici, ?zlem Do?an,Rubin, John R.,Mikolajczyk, Jowita,Salvesen, Guy S.,Powers, James C.

, p. 1553 - 1574 (2007/10/03)

Aza-peptide epoxides, a novel class of irreversible protease inhibitors, are specific for the clan CD cysteine proteases. Aza-peptide epoxides with an aza-Asp residue at P1 are excellent irreversible inhibitors of caspases-1, -3, -6, and -8 with second-order inhibition rates up to 1 910 000 M-1 s-1. In general, the order of reactivity of aza-peptide epoxides is S,S > R,R > trans > cis. Interestingly, some of the R,R epoxides while being less potent are actually more selective than the S,S epoxides. Our aza-peptide epoxides designed for caspases are stable, potent, and specific inhibitors, as they show little to no inhibition of other proteases such as the aspartyl proteases porcine pepsin, human cathepsin D, plasmepsin 2 from P. falciparum, HIV-1 protease, and the secreted aspartic proteinase 2 (SAP-2) from Candida albicans; the serine proteases granzyme B and α-chymotrypsin; and the cysteine proteases cathepsin B and papain (clan CA), and legumain (clan CD).

Kinetics and mechanism of the oxidation of some unsaturated acids by quinolinium bromochromate

Vyas, Shweta,Sharma, Pradeep K.

, p. 820 - 823 (2007/10/03)

The oxidation of maleic, fumaric, crotonic and cinnamic acids by quinolinium bromochromate (QBC) in dimethylsulphoxide (DMSO) leads to the formation of corresponding epoxide. The reaction is of first order with respect to QBC and the acid. The reaction is catalysed by hydrogen ions. The hydrogen-ion dependence has the form: kobs = a + b [H+]. The oxidation of these acids was studied in nineteen different organic solvents. The solvent effect was analyzed by Kamlet's and Swain's multiparametric equations. Solvent effect indicated the importance of the cation-solvating power of the solvent. A mechanism involving a three-centre transition state has been postulated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17015-08-6